Ghaith Aljayyoussi - Concepedia

Author

Ghaith Aljayyoussi

Liverpool School of Tropical Medicine ORCID

Also Known As

Aljayyoussi, Ghaith, G Aljayyoussi, Ghait Aljayyoussi, Ghaith Al-Jayyoussi, Ghaith Aljayyoussi, Rachel S. Owen

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

Liverpool School of Tropical Medicine University of Liverpool Imperial College London Cardiff University Ministry of Health

About

Ghaith Aljayyoussi is an author at Liverpool School of Tropical Medicine specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	402
2	Biochemistry	3	3	69
3	Engineering	2	2	29
4	Natural Sciences	1	1	16
5	Social Sciences	1	1	21

Ghaith Aljayyoussi

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Safety and mosquitocidal efficacy of high-dose ivermectin when co-administered with dihydroartemisinin-piperaquine in Kenyan adults with uncomplicated malaria (IVERMAL): a randomised, double-blind, placebo-controlled trial Menno R. Smit, Eric Ochomo, Ghaith Aljayyoussi, The Lancet Infectious Diseases High-dose IvermectinAntiparasitic AgentMalariaPharmacologyKenyan Adults	2018	138
Ivermectin as a novel complementary malaria control tool to reduce incidence and prevalence: a modelling study Hannah Slater, Brian D. Foy, Kevin C. Kobylinski, The Lancet Infectious Diseases Antiparasitic AgentMalariaImmunologyParasite ControlModelling Study	2020	89
Preclinical development of an oral anti- <i>Wolbachia</i> macrolide drug for the treatment of lymphatic filariasis and onchocerciasis Mark J. Taylor, Thomas W von Geldern, Louise Ford, Science Translational Medicine	2019	82
Short-Course, High-Dose Rifampicin Achieves Wolbachia Depletion Predictive of Curative Outcomes in Preclinical Models of Lymphatic Filariasis and Onchocerciasis Ghaith Aljayyoussi, Hayley E. Tyrer, Louise Ford, Scientific Reports	2017	76
Saliva Alternative to Upper Respiratory Swabs for SARS-CoV-2 Diagnosis Rachel L. Byrne, Grant A. Kay, Konstantina Kontogianni, Emerging infectious diseases	2020	76
AWZ1066S, a highly specific anti- <i>Wolbachia</i> drug candidate for a short-course treatment of filariasis W. David Hong, Farid Benayoud, Gemma L. Nixon, Proceedings of the National Academy of Sciences	2019	65
Pharmacokinetics/pharmacodynamics of chloroquine and artemisinin-based combination therapy with primaquine André Daher, Ghaith Aljayyoussi, Dhélio B. Pereira, Malaria Journal	2019	63
A tetraoxane-based antimalarial drug candidate that overcomes PfK13-C580Y dependent artemisinin resistance Paul M. O’Neill, Richard K. Amewu, Susan A. Charman, Nature Communications	2017	61
Dose prediction for repurposing nitazoxanide in SARS‐CoV‐2 treatment or chemoprophylaxis Rajith K. R. Rajoli, Henry Pertinez, Usman Arshad, British Journal of Clinical Pharmacology	2020	56
Rational Design, Synthesis, and Biological Evaluation of Heterocyclic Quinolones Targeting the Respiratory Chain of <i>Mycobacterium tuberculosis</i> W. David Hong, Peter Gibbons, Suet C. Leung, Journal of Medicinal Chemistry	2017	51

Page 1